Related Experiment Videos
Quantification of HIV-1 using multiple competitors in a single-tube assay
T Vener1, M Axelsson, J Albert
1KTH, Royal Institute of Technology, Swedish Institute for Infectious Disease Control, Stockholm, Sweden.
Biotechniques
|August 1, 1996
Summary
Quantifying human immunodeficiency virus type 1 (HIV-1) DNA is now more accurate using competitive PCR and fragment analysis. This method precisely measures viral load in clinical samples for disease monitoring.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Accurate quantification of human immunodeficiency virus type 1 (HIV-1) DNA is crucial for managing patient care.
- Existing methods may have limitations in precision and variability for clinical applications.
Purpose of the Study:
- To develop and validate a novel method for precise HIV-1 DNA quantification.
- To establish a reliable tool for monitoring disease progression and treatment efficacy.
Main Methods:
- Development of a competitive PCR assay using semi-nested primers.
- Co-amplification of clinical samples with known amounts of three distinct cloned competitors.
- Utilizing a fluorescent-labeled primer for discrimination via automated fragment analysis.
- Construction of a calibration curve based on competitor peak areas for quantification.
Main Results:
- The developed method demonstrated accurate determination of target HIV-1 DNA amounts.
- Minimal variations were observed, indicating high precision and reliability.
- The assay successfully differentiated between wild-type HIV-1 DNA and competitors.
Conclusions:
- Competitive PCR combined with fragment analysis offers a robust method for HIV-1 DNA quantification.
- This technique is suitable for application in clinical settings.
- The method provides a valuable tool for effective disease management and therapeutic monitoring.